|
|
Дата |
|---|
| 30.10.2026 |
| 29.10.2026 |
| 28.10.2026 |
| 27.10.2026 |
| 26.10.2026 |
| 23.10.2026 |
| 22.10.2026 |
| 21.10.2026 |
| 20.10.2026 |
| 19.10.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
35 700.00
|
35 050.00
|
35 700.00
|
35 050.00
|
|
|
10 650 000.00
|
|
|
|
|
35 000.00
|
35 000.00
|
36 000.00
|
35 500.00
|
|
|
113 030 000.00
|
|
|
|
|
35 050.00
|
35 000.00
|
35 200.00
|
35 000.00
|
|
|
269 910 000.00
|
|
|
|
|
35 500.00
|
35 500.00
|
35 800.00
|
35 800.00
|
|
|
32 040 000.00
|
|
|
|
|
35 250.00
|
35 250.00
|
35 900.00
|
35 800.00
|
|
|
483 850 000.00
|
|
|
|
|
36 000.00
|
35 900.00
|
36 000.00
|
35 900.00
|
|
|
14 380 000.00
|
|
|
|
|
36 000.00
|
35 800.00
|
36 000.00
|
36 000.00
|
|
|
147 530 000.00
|
|
|
|
|
35 500.00
|
35 500.00
|
36 200.00
|
36 000.00
|
|
|
121 980 000.00
|
|
|
|
|
36 000.00
|
36 000.00
|
36 250.00
|
36 000.00
|
|
|
25 230 000.00
|
|
|
|
|
35 000.00
|
35 000.00
|
36 250.00
|
36 250.00
|
|
|
49 190 000.00
|
|
Период |
|---|
| 2025, регулярные |
| 2025, регулярные |
| 2024, регулярные |
| 2023, регулярные |
| 2023, регулярные |
| 2020, регулярные |
| 2019, регулярные |
| 2018, регулярные |
| 2017, регулярные |
| 2016, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
21.07.2026
|
22.07.2026 |
2000 VND |
|
31.12.2025
|
05.01.2026 |
2000 VND |
|
13.06.2025
|
16.06.2025 |
2000 VND |
|
17.06.2024
|
18.06.2024 |
2000 VND |
|
16.01.2024
|
17.01.2024 |
2000 VND |
|
19.01.2021
|
20.01.2021 |
2000 VND |
|
01.01.2020
|
02.01.2020 |
2000 VND |
|
04.01.2019
|
07.01.2019 |
2000 VND |
|
27.12.2017
|
28.12.2017 |
2000 VND |
|
03.01.2017
|
04.01.2017 |
2000 VND |
Traphaco JSC is a Vietnam-based pharmaceutical manufacturer. The Company manufactures and trades pharmaceutical products, chemicals, functional food, cosmetic products and other medical equipment and supplies. It is also involved in the cultivation and processing of drug materials, medical technology transfer, as well as the provision of consulting services in the pharmaceutical industry.
